P38 Kinase inhibitor 8
P38 Kinase inhibitor 8 (Compound CCLXXVIII) is the orally active inhibitor for p38β and JNK2α2 with IC50s of 6.3 nM and 53.6 nM. p38 Kinase inhibitor 8 exhibits anti-inflammatory effect in rats collagen-induced arthritis models[1].
Product Specifications
CAS Number
815595-25-6
UNSPSC
12352005
Target
JNK; p38 MAPK
Related Pathways
MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
O=C(C)N1CCC(CC1)NC2=NC(C3=C(C4=CC=C(C=C4)F)N=C5OC=CN53)=CC=N2
Molecular Formula
C22H21FN6O2
Molecular Weight
420.44
References & Citations
[1]Ashwell M, et al., Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38. WO2004110990
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880391-100 1x 100 µL
CD81 / TAPA-1 (1.3.3.22), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470460-500 1x 500 µL
CD44 Standard (156-3C11), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740158-100 1x 100 µL
Cytokeratin 17 (E3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471081-100 1x 100 µL
CD45RO (190-2F2.5), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details